| Ascorbate prophylaxis with mitomycin-C for corneal haze after laser-assisted sub-epithelial keratectomy. | |
| | |
MedLine Citation:
|
PMID: 22891401 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
BACKGROUND: Corneal haze is a significant complication of photorefractive keratectomy (PRK) and laser-assisted subepithelial keratectomy (LASEK). OBJECTIVES: To evaluate the effect of ascorbic acid supplementation in addition to perioperative topical mitomycin-C for the prevention of haze after LASEK. METHODS: We performed a retrospective, non-randomized case series study of two groups of 48 consecutive patients (96 myopic eyes) who had LASEK surgery. The treatment group was given ascorbic acid (vitamin C) orally, 500 mg, twice daily from 1 week before to 2 weeks after surgery. The control group was not offered any additional treatment. Ascorbate supplementation was the only difference in the postoperative treatment protocol between the treatment and control groups. Haze was assessed on a scale from 0 to 4 at the 1 year visit. RESULTS: Overall, 33.3% and 37.5% of the patients in the treatment and control groups respectively developed corneal haze. The trend of increased haze severity in the control group did not reach statistical significance. CONCLUSIONS: Our results showed that systemic ascorbate supplementation does not have an additional effect on the prevention of haze after LASEK compared to the effect of topical mitomycin-C alone. |
| | |
Authors:
|
Michael Yulish; Itzchak Beiran; Benjamin Miller; Joseph Pikkel |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Israel Medical Association journal : IMAJ Volume: 14 ISSN: 1565-1088 ISO Abbreviation: Isr. Med. Assoc. J. Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-08-15 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100930740 Medline TA: Isr Med Assoc J Country: Israel |
Other Details:
|
Languages: eng Pagination: 382-5 Citation Subset: IM |
Affiliation:
|
Department of Ophthalmology, Ziv Medical Center, Safed, Israel. yulishmichael@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Epidemiology of cleft lip and palate among Jews and Bedouins in the Negev.
Next Document: Clinical efficacy and adverse effects of golimumab in the treatment of rheumatoid arthritis.